Mark Hazeltine

Track

Insider profile

Currently holds a position at Exagen Inc

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President - Finance Exagen Inc June 1, 2017 -
Mark Hazeltine's trades of Exagen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Exagen Inc (XGN)
Transaction date
Sale
Price
186.01
Quantity 87,691
Value US$2,903,531
US Exagen Inc (XGN)
Transaction date
Sale
Price
106.62
Quantity 62,908 +45.9%
Value US$2,186,254
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-03 2023-03-02
US Exagen Inc (XGN)
S Sale
87,691
186.01
US$2,903,531 		87,691 186.01 US$2,903,531
2023-02-10 2023-02-08
US Exagen Inc (XGN)
S Sale
62,908 +45.9%
106.62
US$2,186,254 		62,908 +45.9% 106.62 US$2,186,254